萘呋胺酯草酸盐
|
|
|
- CAS号:
- 3200-06-4
- 英文名:
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- 英文别名:
- ls121;Iridus;eu-1806;CLARANTIN;Acid oxalate;NAFRONYL OXALATE;naftidrofuryloxalate;Nafronyl acid oxalate;hylester,oxalate(1:1);NAFRONYL OXALATE SALT
- 中文名:
- 萘呋胺酯草酸盐
- 中文别名:
- 萘呋胺酯;草酸萘呋胺;萘呋胺草酸盐;草酸萘呋胺氢;萘呋胺酯草酸盐;硝基呋喃草酸氢盐;萘呋胺酯草酸盐 标准品;Α-(1-萘基甲基)-2-四氢呋喃丙酸二乙氨基乙酯;Α-(1-萘甲基)-2-四氢呋喃丙酸二乙胺基乙基酯草酸盐;alpha-(1-萘甲基)-2-四氢呋喃丙酸二乙胺基乙基酯草酸盐
- CBNumber:
- CB5426302
- 分子式:
- C26H35NO7
- 分子量:
- 473.56
- MOL File:
- 3200-06-4.mol
|
|
|
萘呋胺酯草酸盐化学性质
-
熔点:
-
110-111°
-
|
-
沸点:
-
574°C (rough estimate)
-
|
-
密度:
-
1.2205 (rough estimate)
-
|
-
折射率:
-
1.6000 (estimate)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Freely soluble in water, freely soluble or soluble in ethanol (96 per cent), slightly or sparingly soluble in acetone.
-
|
萘呋胺酯草酸盐性质、用途与生产工艺
萘呋胺酯草酸盐为有机酸物质，其是脑血管和外周血管的扩张剂；拮抗5-羟色胺及缓激肽的作用；可使细胞内ATP增多以改善细胞代谢；降低血液及血浆的粘稠度及纤维蛋白原浓度；增加细胞的氧化能力，对细胞缺氧具保护作用；此外具有罂粟碱样的解痉作用，缓慢而持久。
萘呋胺酯草酸盐是一种用于治疗心脑血管与周围血管疾病的药物，具有如下特点：其扩张作用比烟酸强，增强脑血管流量的作用较罂粟缓慢而持久。据认为其临床应用比罂粟碱安全，对严重下肢动脉炎的疗效较烟胺羟丙茶碱显著而迅速。
萘呋胺酯草酸盐是一种用于治疗心脑血管与周围血管疾病的药物。其具有如下特点：其扩张作用比烟酸强，增强脑血管流量的作用较罂粟缓慢而持久。
Naftidrofuryl oxalate (Nafronyl oxalate salt) 是在外周血和脑血管病症如血管扩张药的管理中使用的药物, 增加细胞氧化能力, 且是一种 5-HT2 受体拮抗剂。
| Target | Value |
5-HT2 receptor
()
|
Naftidrofuryl oxalate (Nafronyl oxalate salt) may be effective for relieving the pain of muscle cramps.
Naftidrofuryl oxalate (Nafronyl oxalate salt) is the only vasoactive drug for peripheral arterial disease (PAD) which is likely to be cost-effective.
Naftidrofuryl oxalate (Nafronyl oxalate salt) is ranked first for both maximum walking distance (MWD) and pain-free walking distance (PFWD) (probability of 0·947 and 0·987, respectively, of being the best treatment) followed by cilostazol and pentoxifylline. Naftidrofuryl oxalate (Nafronyl oxalate salt) is effective treatments for claudication, Naftidrofuryl oxalate is likely to be the most effective, with minimal serious adverse events.
萘呋胺酯草酸盐
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/04/30 | HY-B1107 | 萘呋胺酯草酸盐
Naftidrofuryl oxalate | 3200-06-4 | 100mg | 500元 |
| 2024/04/30 | HY-B1107 | 萘呋胺酯草酸盐
Naftidrofuryl oxalate | 3200-06-4 | 10mM * 1mLin DMSO | 550元 |
萘呋胺酯草酸盐
生产厂家
全球有 91家供应商
萘呋胺酯草酸盐国内生产厂家
3200-06-4, 萘呋胺酯草酸盐 相关搜索:
- CASODEX
- 药靶配体
- 原料药
- 化工原料
- 医药原料
- 小分子抑制剂
- Alphabetic
- Analytical Chromatography Product Catalog
- Analytical Standards
- NA - NI
- C26H34NO7
- C24H33NO3C2H2O4
- 硝基呋喃草酸氢盐
- 萘呋胺草酸盐
- 草酸萘呋胺氢
- 萘呋胺酯草酸盐 标准品
- 萘呋胺酯草酸盐
- 草酸萘呋胺
- alpha-(1-萘甲基)-2-四氢呋喃丙酸二乙胺基乙基酯草酸盐
- Α-(1-萘基甲基)-2-四氢呋喃丙酸二乙氨基乙酯
- Α-(1-萘甲基)-2-四氢呋喃丙酸二乙胺基乙基酯草酸盐
- 萘呋胺酯
- 3200-06-4
- 2-Furanpropanoic acid, tetrahydro-a-(1-naphthalenylmethyl)-,2-(diethylamino)ethyl ester, ethanedioate (1:1)
- 5-hydroxytryptamine Receptor,Inhibitor,Naftidrofuryl oxalate,Serotonin Receptor,Naftidrofuryl,inhibit,5-HT Receptor,Nafronyl
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate USP/EP/BP
- Nafronyl oxalate salt USP/EP/BP
- Acid oxalate
- α-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- Nafronyl oxalate salt ,98%
- Nafronyl oxalate salt ,99%
- 2-(DiethylaMino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)Methyl)propanoate oxalate
- Nafronyl oxalate salt ,96%
- Iridus
- 2-Furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl esteroxalate (1:1)
- 2-Furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl ester oxalate (1:1)
- 2-Furanpropanoic acid, tetrahydro-.alpha.-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester, ethanedioate (1:1)
- 2-(Diethylamino)ethyl tetrahydro-.alpha.-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1)
- NAFRONYL OXALATE SALT
- NAFRONYL OXALATE
- ALPHA-[1-NAPHTHYLMETHYL]-2-TETRAHYDROFURANPROPIONIC ACID DIETHYLAMINOETHYL ESTER OXALATE SALT
- alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate
- α-(1-naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester
- Nafronyl acid oxalate
- CLARANTIN
- diethyl[2-[2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy]ethyl]ammonium hydrogen oxalate
- naftidrofuryloxalate
- ls121
- hylester,oxalate(1:1)
- eu-1806
- 2-(diethylamino)ethyltetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionateo